Results 81 to 90 of about 24,931 (232)
Myeloid Leukemia and Cutaneous Histiocytosis: fortuitous encounter? [PDF]
Background: Histiocytosis encompass highly heterogeneous proliferative disorders of the mononuclear phagocyte system. Recently they have been reclassified by the Histiocyte Society (2016) and reviewed in WHO classifications of hematopoietic (2017) and ...
Chiara Moltrasio +9 more
core +1 more source
MEK inhibition achieves robust and durable responses in Erdheim–Chester disease [PDF]
Abstract Erdheim–Chester disease (ECD) is a rare histiocytic neoplasm characterized by heterogeneous clinical manifestations and limited evidence to guide targeted therapy. While MEK inhibitors (MEKi) are increasingly used, data on their real‐world efficacy, durability, and safety remain incomplete.
Pegoraro F +34 more
europepmc +2 more sources
Histiocytes: Multifaceted Regulators of Health and Disease
ABSTRACT The mononuclear phagocyte system encompasses macrophages, dendritic cells (DCs), and monocytes. Tissue‐resident macrophages and dendritic cells arise during embryogenesis and are replenished either through self‐renewal or by monocytes during inflammation.
Erika J. Gruber
wiley +1 more source
S, Bor, I, Smith, M, Feiwel
openaire +2 more sources
Fine‐Needle Aspirate Cytology of Feline Pulmonary Langerhans Cell Histiocytosis in Two Cats
ABSTRACT Feline pulmonary Langerhans cell histiocytosis (FPLCH) is a rare histiocytic disorder in cats, usually diagnosed post‐mortem following natural death or euthanasia for severe respiratory distress. Antemortem diagnosis has been reported only once, achieved by cytologic examination of bronchoalveolar lavage fluid combined with immunocytochemistry,
Karuna Katariwala +7 more
wiley +1 more source
Histiocytosis in Nigerian children: A report of two variants
Histiocytoses are a rare group of proliferative disorders with very similar clinical and histological pictures. We present a case report of two variants seen in an eight month old female and five month old male in a tertiary hospital in southern Nigeria.
Udo E +3 more
doaj
De‐Escalation of Neoadjuvant Treatment for HER2‐Positive Breast Cancer
ABSTRACT With improved prognosis in early HER2‐positive breast cancer, safely de‐escalating treatment is increasingly investigated to minimize overtreatment. This article focuses on neoadjuvant de‐escalation strategies for HER2‐positive breast cancer.
Yiyin Ma, Dedian Chen, Sheng Huang
wiley +1 more source

